Ci Private Wealth, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Ci Private Wealth, LLC
- $56.4 Billion
- Q2 2024
A detailed history of Ci Private Wealth, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 127,579 shares of EYPT stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,579
Previous 52,898
141.18%
Holding current value
$1.48 Million
Previous $1.09 Million
1.46%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
57.2MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$96.5 Million5.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$60 Million1.88% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$43.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.65MShares$42.3 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$41.6 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $395M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...